Men with severe infertility suffer a high risk of Y chromosome deletion, hence screening for these cases is recommended prior to treatment with assisted reproduction. Our study aimed to investigate and detect the azoospermia factor (AZF) region deletion, rearrangement and deleted azoospermia (DAZ) gene copy number variations in Egyptian azoospermic infertile men. This was tested on 54 Egyptian nonobstructive azoospermic (NOA) infertile men, with age ranged from 21 to 45 years (mean: 31.4 ± 6.1 years), by STS ± multiplex PCR using a set of 14 sequence tagged sites (STSs) from three different regions of the Y chromosome: AZFa, AZFb, AZFc and sY587/DraI PCR-RFLP assay to determine DAZ copy number variations. The results revealed a significant prevalence of AZFc subtypes deletion and reduced DAZ gene dosage in Egyptian azoospermic cases affecting Y chromosome deletions. To our knowledge, this study is the first one to investigate AZFc subtypes deletion and DAZ gene dosage in Egyptian infertile men. We concluded that DAZ genes deletion is a risk factor for spermatogenic damage.
INTRODUCTION
Primary infertility is the inability of a sexually active, noncontracepting couple to achieve pregnancy in 1 year.
1 This is considered a major reproductive health problem today that affects 10 to 22% of couples in the human population. In about 50% of these couples, the underlying problem lies in the male, either solely or in combination with female factor. [2] [3] [4] [5] Screening for Y chromosome microdeletions before intracytoplasmic sperm injection is often underdetermined. Therefore, the present study is aimed to investigate the 
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frequencies of Y chromosome microdeletion, definitely in azoospermia factor (AZF), in Egyptian nonobstructive azoospermic (NOA) infertile men. Furthermore, the present study was designed to determine the frequency of copy number variations of one of testis specific genes named deleted azoospermia (DAZ) gene that is confirmed by AZFc rearrangement.
MATERIALS AND METHODS
Male subjects with primary infertility attending the clinical genetics clinic at the National Research Centre (NRC) and andrology clinic at the Kasr Al Ainy Hospital, Cairo University (Egypt), were enrolled in the present study after ensuring that they are NOA. All tests using human samples were carried out with informed consent according to ethical committee instructions of NRC.
SELECTION OF CASES
During January 2011 to September 2012, a total of 54 cases with azoospermia were studied according to selection criteria, including only cases suffering of primary infertility, in a middle reproductive age (20-45 yrs) , had repeated seminal analysis (two at least, to ensure that they are azoospermic even after centrifugation), performed karyotypes to classify the cases to group having chromosomal aberration and another not having chromosomal aberration. All the included cases signed the informed consent. Exclusion criteria included cases with varicocele, obstruction of the seminal tract, pituitary failure or any other causes of testicular damage or exposure to infection or radiation.
Thirty fertile control cases, matched with respect to age, were selected as control group. All members of the control group were healthy men with normal reproductive history (with one or more children in the last 3 years), normal physical examination and normal sperm concentration (more than 15 × 106 spz/ml).
CLINICAL EVALUATION
Each patient was carefully examined clinically to rule out other causes of infertility. A detailed family, occupational and reproductive history were evaluated. Pedigree analysis for three generations was constructed to rule out consanguinity. Specific and local examination of the external genitalia with scoring the testicular size using the orchidometer, penile length, size and scrotal development were evaluated.
Signs of Klinefelter (KF) syndrome were reported for each case mainly; tall stature, underdeveloped of secondary sexual characters, testicular atrophy, feminine distribution of fat and others.
CYTOGENETIC STUDIES
Peripheral blood lymphocyte cultures and G-banding technique were done for 54 patients according to the standard method. 6 High resolution using method of synchronization was done according to the method of Yunis et al 7 for some cases. A total of 25 metaphases were analyzed for each case. Any structural or numerical anomalies were recorded and karyotyped according to the ISCN.
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GENOMIC DNA EXTRACTION
Blood samples were collected using Na2EDTA as anticoagulant inside vacutainer sterile tubes. DNA was isolated from peripheral blood leukocytes by QIAamp DNA Mini Kit (50 prep), cat no. 51304, Germany.
AZF MAPPING
The European Academy of andrology and the European Molecular Genetics Quality Network (EAA/EMQN) guidelines indicate that the use of six STS loci (sY84, sY86, sY127, sY134, sY254, sY255) result in the detection of up to 95% of all reported Y-chromosome microdeletions in the AZF regions. 9 Additional STS loci can then be used to define the deletion breakpoints further. An STS was considered absent only after at least two amplifications failure in the presence of successful amplification of control (SRY-sY14 Table 1 ). The PCR product was digested by fast digest DraI restriction enzyme for 5 minutes at 37ºC. Finally, the digested products were run on a 3% agarose gel containing ethidium bromide and visualized by UV transilluminator.
Stage III-Typing of AZFc Subdeletions
This stage aimed to confirm the results of stage II through AZFc rearrangements analysis using seven AZFc-specific sequence tagged sites (STSs) (sY1191, sY1291, sY1206, sY1201, sY1258, sY1054, sY1161) to identify the subtypes of AZFc deletions. The AZFc rearrangement analysis results were interpreted according to Table 2 . [11] [12] [13] [14] Detailed sequences of the all primers that used in molecular studies were given in Table 3 .
STATISTICAL ANALYSIS
Statistical analysis was performed using the statistical package SPSS for Windows (version 17; SPSS, Chicago, IL, USA). Data were presented as frequencies and statistical evaluation was performed by Chi-squared test (χ 2 ) to statistic the significance of differences among these frequencies. 
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ETHICAL CONSIDERATIONS
• Written consent was taken from every case sharing in the study.
• The participants were informed about the purpose of the study.
• All the steps of the tests were explained to the patient with all its possible complications.
• All patients' clinician data and test results are confidential.
RESULTS
• Clinical analysis: The mean age of cases was 31. From combining molecular and karyotyping data, we found no significant difference between frequency of sex chromosomal anomalies and frequency of sex chromosomal normality in Y microdeleted cases, data showed in Table 6 .
AZFc subdeletion typing analysis was reported that, among the 10 cases, that had AZFc aberrations, five cases had gr/gr subtype with DAZ1/2 deletion (5/10, 50%), three cases had b2/b4 subtype with DAZ1/2/3/4 deletion (3/10, 30%), and two cases (46, XX male with positive SRY gene) accounted as b2/b4 subtype because they had no Y chromosome. Only one case (case no. 37) had a microdeletion outside the DAZ region, as shown in Table 7 and Figs 1 to 3C.
Regarding total number of cases included in the present study, Yq mapping analysis results were summarized in Table 8 .
Therefore, in the azoospermic infertile men included in this study, there was a significant difference between the prevalence of AZFc aberration and AZFa+b aberration and a significant difference between the prevalence of AZFc aberrations combined with reduced DAZ dosage and AZFc aberrations not combined with reduced DAZ dosage.
All normozoospermic fertile men had no detected AZF deletions using the same technique.
DISCUSSION
It has long been recognized that Y chromosome microdeletions and chromosomal anomalies are closely related to male infertility. However, few studies have specifically examined the general characteristics of the whole AZF region and its rearrangements in NOA infertile men in Egypt. Additionally, these Y chromosome microdeletions cannot be predicted cytogenetically, on the basis of clinical findings or by semen analysis. Thus, PCR-based AZF screening for Yq microdeletions is necessary.
In the past, the diagnosis of a genetic etiology had little clinical significance. But recently, with the advent of assisted reproductive technology and our knowledge of the vertical iatrogenic transmission of these genetic anomalies to the offspring, diagnosing the presence of these deletions has become very important. Diagnosis not only aids in determining the prognosis in these infertile cases, but provides the information necessary to counsel these couples effectively, particularly with regard to the birth of infertile male offspring who may have the same or secondary, and larger deletions with more severe testicular phenotype. Selection of an appropriate combination of sequence tagged site (STS) loci is critical in the determination of Y-chromosome microdeletion frequency. The European Academy of Andrology and the European Molecular Genetics Quality Network guidelines indicate that the use of six STS loci (sY84, sY86, sY127, sY134, sY254, sY255) results in the detection of up to 95% of all reported Y chromosome microdeletions in the AZF regions. 9 Additional STS loci can then be used to define the deletion breakpoints further.
According to the European Association of Urology Guidelines on Male Infertility (The 2012 update), the highest frequency of classical Y microdeletions is found in men with azoospermia (8-12%) followed by those with oligozoospermia (3-7%). 16 The frequency and type of Y chromosome microdeletions varied according to ethnic, regional differences, selection criteria for patient samples or methodological differences. 17 In this study, 20.4% of the studied Egyptian NOA infertile men had Yq deletions; on the other side, Medica et al 18 found no Y chromosome microdeletions in NOA men in Croatia (Europe), India, Taiwan (Asia) and Morocco (Africa). [19] [20] [21] According to EAA/EMQN guidelines (2004 to 2012), about 90% of NOA men have not any classical Y microdeletions. So in this work, we performed more specific mapping to a whole AZF region to include DAZ gene dosage that was confirmed by AZFc subtypes assay. Therefore, we found a significant prevalence of reduced DAZ gene dosage (90.9%) among Egyptian NOA men.
Seven studies reported the highest frequency of microdeletions in the AZFc region. 15, [22] [23] [24] [25] 26, 27 According to our results, we found that certain deletion patterns could be related to the Egyptian cases, where AZFc deletion with reduced DAZ gene copy number accounting 72.7% of cases had AZF deletion.
We found frequency of a certain STS markers lower in Egyptian cases than China ones, where Dai et al 27 reported
94.1% deletion in sY254 and 94.1% deletion in sY255, but this work reported 50% deletion in sY254 and 50% deletion in sY255. In this work, the frequency of DAZ1/2 deletion among Egyptian NOA men was 9.3% and 5.6% for DAZ1/2/3/4 deletion, and no found any cases had only DAZ2/3 deletion. Therefore, this frequency was considered compatible with others because there are studies which have shown that in the Caucasian population 15% of idiopathic azoospermia cases had deletion of either 4 DAZ genes or DAZ1/DAZ2 in AZFc region, and 8.8% of china azoospermic patients had complete deletion of DAZ genes, and DAZ1/DAZ2 deletion was confirmed in 8.3 of azoospermic patients. 11, 15, 31 Figs 3A to C: (A) STS ± multiplex PCR amplified products of sY1291 and sY1191 of AZFc subdeletion showed that cases no. 9, 14, 18 and 23 had gr/gr deletion type, where sY1291 was deleted, (B) agarose gel electrophoresis for restriction enzyme assay by Dra I showed that case no. 9 had absent 122 bps fragment, indicating that DAZ1/2 were deleted, (C) STS ± multiplex PCR amplified products of sY254, 86, 127 and SRY showed that case no. 7 had sY254 deletion, PHI-174/Hae III marker (M) In this work, the recorded increased prevalence of AZFc deletion in infertile men, who had Yq deletions, represents a risk factor for male infertility, and among eight cases had AZFc deletions, mostly were of the gr/gr subtype (62.5%) followed by b2/4 subtype (37.5%).
Our findings are in agreement with and further support other preliminary reports done on AZFc deletions. 12, 31, 32 These studies suggested that the gr/gr deletion and the g1/g2, which remove DAZ copies 1 and 2, represented a risk factor for spermatogenic damage. In contrast, the b2/b3, gr/gr and g1/g3 deletions, which remove DAZ copies 3 and 4, seemed to have no or little effect on fertility.
CONCLUSION AND RECOMMENDATIONS
To our knowledge, the previous Egyptian studies [33] [34] [35] of male infertility were not investigated AZFc subtypes deletion and DAZ gene copy number variation, so this is the first study manipulated genetic mapping of AZFc region to investigate the prevalence of AZFc subtypes deletion and DAZ gene dosage in Egyptian azoospermic infertile men. Microdeletion analysis using STS ± multiplex PCR and PCR-RFLP could be sufficient tool to determine the frequency, mapping and site of gene deletion. DAZ genes deletion is a risk factor for spermatogenic damage. According to this work, the frequency and type of Y chromosome microdeletions varied by ethnic and regional A B C differences. So, we recommend adding the DAZ gene dosage investigation in EAA/EMQN classical Y microdeletions protocol for Egyptian NOA cases, especially that DAZ gene abnormality could be transmitted from the father to his offspring after successful intracytoplasmic sperm injection (ICSI). Also, we recommend studying the prevalence of Y microdeletion in Egyptian NOA infertile men population using more cases and STS markers.
